Long-Term Medicaid Excess Payments from Alleged Price Manipulation of Generic Lorazepam

BACKGROUND: Cost savings from the use of generic drugs versus brand-name drugs are well known. Both private and public prescription drug plans encourage the use of generic drugs through a variety of mechanisms. The magnitude of cost savings for a given generic drug is dependent on the degree to whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Boyang, Gorevski, Elizabeth, Kelton, Christina M.L., Guo, Jeff J., Boone, Jill E. Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437366/
https://www.ncbi.nlm.nih.gov/pubmed/22971204
http://dx.doi.org/10.18553/jmcp.2012.18.7.506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437366/
https://www.ncbi.nlm.nih.gov/pubmed/22971204
http://dx.doi.org/10.18553/jmcp.2012.18.7.506

Ejemplares similares